For rapid capture with high yield, choose a His-tag. For maximum native purity, choose Strep-tag or a TAP system. For solubility problems, choose MBP or GST. For detection or low-abundance targets, choose small epitope tags such as FLAG or HA. Most fusion constructs also typically include a protease cleavage site built in from the start, and independent validation of the antibody or resin you pair with a tag, which ABMIUM provides, removes much of the guesswork from that decision.
TL;DR:
- His-tags are ideal for rapid, high-yield protein capture, but often require a polishing step for purity due to background contamination.
- For native purity, Strep-tag or TAP systems are preferred, as they provide lower background and preserve protein folding.
- Solubility issues can often be solved with MBP or GST fusions, especially when expressed in bacterial hosts prone to inclusion bodies.
- Small epitope tags like FLAG or HA are suitable for detection purposes because they minimally disrupt protein function, depending on antibody quality.
- Protein and method-specific factors, such as tag placement and host organism, critically influence the success of purification and downstream assays.
Table of Contents
- Protein tag selection by experimental goal
- Tag families, sizes and purification chemistry compared
- How your protein and your method should drive the decision
- Which host organism should shape your tag choice?
- Tag removal: choosing a protease and confirming a clean cut
- A step by step workflow for selecting and testing a tag
- How ABMIUM supports tag based purification and detection
- Can a protein tag trigger an immune response in your system?
- What the evidence actually supports, and where it does not
- Source verified reagents for every tag based workflow
- Sources
- FAQ
Protein tag selection by experimental goal
The right tag depends on what you are actually trying to produce, not which tag happens to be sitting in your lab’s plasmid collection. A PMC review of affinity tags frames this well: tag choice should follow from the desired final product, meaning the quantity and purity you need, rather than habit or convenience.
Here is how that logic plays out against common goals:
- Rapid capture or high yield: His-tag paired with immobilised metal affinity chromatography (IMAC) is fast and cheap, but typical purity runs 20 to 80% depending on expression, so plan a polishing step such as size exclusion chromatography (SEC) if you need a clean final sample.
- Maximum native-state purity: Strep-tag with Strep-Tactin resin, or a tandem affinity purification (TAP) tag, gives lower binding capacity than His but far less background, with gentle desthiobiotin elution that preserves folding for structural or biophysical work.
- Poor solubility or low expression: MBP or GST fused at the N-terminus often rescues otherwise insoluble targets, and Cytiva’s guidance on tagged protein purification notes that a solubility tag and a detection tag can be combined in the same construct when the two needs conflict.
- Detection or minimal interference with function: FLAG, HA, Myc, or V5 tags are short and hydrophilic, so they rarely disrupt folding, though results depend entirely on antibody quality.
- Immobilisation or surface plasmon resonance (SPR): biotin/BCCP tagging binds streptavidin surfaces almost irreversibly, which is ideal for capture but can make elution and eukaryotic-lysate background a real headache.
Tag families, sizes and purification chemistry compared
Every tag trades size against function, and function against how easy the protein is to get clean. The table below collects the working numbers you need when sketching a construct.
A few of these deserve a caveat beyond the table. Anti-His antibodies can cross-react with endogenous histidine-rich proteins in some lysates, inflating background on a western blot. GST fusions dimerise, which has occasionally masked catalytic activity in enzyme assays until researchers cleaved the tag off. Thermo Fisher’s guidance on epitope tags also flags fluorescent fusion tags such as GFP or mCherry, at roughly 27 to 28 kDa, as useful for live-cell imaging but large enough to perturb function in smaller target proteins.
How your protein and your method should drive the decision
A tag that works perfectly on one construct can wreck another, and the difference usually comes down to three things: where the tag sits, how big it is, and what the downstream method demands.
Placement matters because tags near a folding domain or an active site interfere with function far more often than tags on a flexible terminus. If your protein’s N-terminus sits close to a catalytic pocket, move the tag to the C-terminus, or vice versa, before you troubleshoot anything else. Size compounds this: a 1 kDa His-tag rarely bothers a 300 amino acid enzyme, but the same tag on a 40 amino acid peptide can dominate the molecule’s behaviour.
Your downstream method sets hard constraints too. Crystallography usually demands tag removal, since a flexible fusion partner disrupts lattice formation. SPR and other native-interaction assays favour Strep-tag or biotin because they preserve conformation and allow gentle capture. Western blotting tolerates almost any epitope tag, provided the antibody is validated. Immunoprecipitation works best with small tags like FLAG or HA, because bulky fusions such as MBP can sterically block the antibody’s access to nearby residues.
Which host organism should shape your tag choice?
Your expression system narrows the field further, and ignoring this is one of the most common causes of a failed pilot expression.
Escherichia coli handles His-tags well and remains the default for straightforward soluble targets, but it also pushes many proteins into inclusion bodies, particularly larger or membrane-associated ones. When that happens, an MBP or SUMO fusion often improves solubility enough to avoid denaturing conditions altogether. If inclusion bodies are unavoidable, denaturing purification under urea or guanidine changes the picture: His-tag still binds IMAC resin under denaturing conditions, but Strep-tag and antibody-based epitope tags generally do not tolerate the same treatment, so refolding after IMAC capture is usually the safer route.
Mammalian and other eukaryotic systems introduce different problems. Secreted glycoproteins can carry native biotin or histidine-rich regions that create background binding on the very resins you are relying on for specificity, so a pilot small-scale expression before committing to a full purification run is worth the extra week it costs.
Tag removal: choosing a protease and confirming a clean cut
Cleavage strategy deserves its own decision, separate from the tag itself, because the wrong protease choice can leave residual tag sequence or nick your target protein.
- TEV protease cuts with high sequence specificity (ENLYFQ/S) and works at low temperature, making it the safest default for sensitive proteins, though it can be slow.
- Thrombin cuts faster but tolerates more sequence variation, so it occasionally nicks the target protein at secondary sites.
- Factor Xa offers good specificity but is expensive and sensitive to detergents in the buffer.
- SUMO protease cleaves precisely at the SUMO fold boundary and leaves a completely native N-terminus, which matters when even a single extra residue affects downstream assays.
LabOnline’s guidance on purifying tagged proteins recommends designing the cleavage site into the construct from the outset rather than retrofitting it. On-column cleavage saves a step but risks leaving protease in your eluate; off-column cleavage gives cleaner separation if you add a second affinity pass (many proteases carry their own His-tag, so a brief IMAC step removes them). Confirm success with SDS-PAGE against a calibrated protein marker, a mass shift check, or a western blot against the removed tag.
A step by step workflow for selecting and testing a tag
- Define the end goal precisely: crystallography, SPR, western blot, functional assay or simple detection.
- Cross-reference protein size and topology against the tag options in the reference table above, favouring smaller tags for smaller proteins.
- Decide whether native purity or maximum yield matters more; this alone usually splits the choice between Strep/TAP and His.
- Build in a protease cleavage site unless the application specifically tolerates a permanent tag.
- Run a small-scale pilot expression and single-step capture before committing to a full-scale purification.
- Check the pilot on SDS-PAGE: multiple bands suggest degradation or non-specific binding, low yield suggests poor expression or a poorly accessible tag, and high background suggests the resin or antibody needs re-optimising.
- Adjust construct design based on the pilot, then scale up only once the small-scale result is clean.
Pro Tip: Run your pilot purification at the smallest practical scale, a few millilitres of culture is often enough, before you commit reagents and time to a litre-scale expression. It is far cheaper to redesign a construct after a failed 5ml pilot than after a failed 5 litre fermentation.
Watch for three recurring red flags: consistently low yield despite good cell density (often a translation or folding problem, not a tag problem), multiple bands on a reducing gel (frequently proteolytic degradation of an exposed tag), and high background on affinity resin (often resolved by adding a low concentration of imidazole to wash steps for His-tag, or switching to a more selective resin).
How ABMIUM supports tag based purification and detection
Choosing a tag is only half the problem. The reagents you pair with it, whether that is an anti-His antibody, a Strep-Tactin resin, or a secondary detection conjugate, need their own scrutiny, since inconsistent antibody performance is a well documented source of wasted experiments. ABMIUM addresses this by focusing on verified antibody sourcing and pre-purchase validation, so researchers know a reagent’s provenance before it reaches the bench.
ABMIUM’s approach includes:
- Independent validation services that support reproducible science and reduce redundant repeat experiments
- Transparent review of each reagent’s provenance, cutting wasted spending on unreliable antibodies
- Calibrated prestained protein markers for confirming tag cleavage and fusion protein size on SDS-PAGE
- Validated primary antibodies suited to epitope-tag detection workflows
- Comprehensive scientific support, including product comparison, for labs weighing tag and antibody options side by side
Can a protein tag trigger an immune response in your system?
Immunogenicity is rarely a concern in standard in vitro expression and purification, but it becomes relevant the moment a tagged protein moves into an animal model, a cell-based immunoassay, or a therapeutic development pipeline. Epitope tags such as FLAG and HA are foreign peptide sequences, and in vivo administration can, in principle, provoke an antibody response against the tag itself, which complicates interpretation of any subsequent immune readout.
This matters most for in vivo imaging and functional studies in animal models, where an unintended immune reaction against the tag can confound the biology you are actually trying to measure. Fusion tags derived from bacterial or viral proteins, including some larger tags like GST, carry a theoretically higher immunogenic potential than short synthetic epitopes, simply because they present more potential antibody-binding surface.
The practical mitigation is straightforward: for any application involving a live animal, an immune cell assay, or a therapeutic candidate, favour the smallest tag that will still do the job, and where possible plan for tag removal before the protein enters that system. For purely in vitro biochemical or structural work, this consideration drops away almost entirely, which is part of why the goal-led shortlist earlier in this guide separates detection and structural applications so clearly.
What the evidence actually supports, and where it does not
The flow-chart logic in the PMC review holds up well under scrutiny: match the tag to the final product you need, not to whichever plasmid backbone is already on the bench. What the conventional advice underplays is how often the pilot expression step gets skipped entirely. Labs commit to a full-scale purification on the strength of a literature precedent, then spend weeks troubleshooting a tag that was never going to behave with their specific construct.
The other gap is validation. Plenty of guidance covers tag chemistry in detail, IMAC conditions, elution buffers, protease specificity, but says almost nothing about whether the antibody or resin batch on the bench actually performs as advertised. That is not a minor omission. A poorly validated anti-His antibody produces exactly the same symptom as a genuinely failed purification: a smeared blot and no confidence in the result. Independent validation, the kind ABMIUM builds into its sourcing process, closes that gap in a way that generic tag-selection advice simply does not address. Prioritise the pilot, then prioritise the reagent, in that order.
— Veron
Source verified reagents for every tag based workflow
Selecting the right tag solves half the problem; sourcing a reagent that performs as claimed solves the other half, and that second half is where most wasted lab budget actually goes. ABMIUM exists specifically for that second problem: every antibody and detection reagent in its catalogue goes through pre-purchase validation and transparent provenance review, so you are not gambling institutional funds on an unverified lot number.
If your current project involves detecting a His, FLAG or HA-tagged construct, a validated anti-tag antibody removes one variable from an already complex purification workflow. Labs confirming cleavage efficiency or fusion protein size can pair that with a calibrated prestained marker for accurate molecular weight reference on SDS-PAGE. ABMIUM also offers independent validation services for researchers who want a second opinion on a reagent before it goes into a critical experiment, along with institutional contract pricing for labs ordering at scale. Browse the full catalogue and check reagent availability before your next pilot expression run.
Sources
- Overview of affinity tags for protein purification - PMC
- Considerations When Using Epitope Tags (Thermo Fisher)
- Tagged protein purification (Cytiva)
- Purifying tagged proteins (LabOnline)
FAQ
What are the different types of protein tags?
The main categories are affinity tags for purification (His-tag, GST, MBP, Strep-tag), epitope tags for detection (FLAG, HA, Myc, V5), and specialised tags for particular workflows such as SUMO, TAP, and biotin/BCCP for immobilisation.
What is the 6×His-tag sequence?
The 6×His tag consists of six consecutive histidine residues (HHHHHH) added to the N-terminus or C-terminus of a protein, allowing it to bind nickel or cobalt resin during IMAC purification.
Why use FLAG tag and HA tag together or separately?
FLAG and HA tags are short, hydrophilic epitope tags that rarely interfere with protein folding, and researchers choose one over the other largely based on antibody availability and cross-reactivity in their specific system; using both on the same construct allows two independent detection routes.
How many kDa is a 6×His-tag?
A 6×His tag is roughly 1 kDa (six histidine residues plus any linker sequence), which is small enough that it rarely affects the folding or function of most target proteins.